Literature DB >> 2731100

Attitudes and practices of primary care physicians in the management of elevated serum cholesterol levels.

N R Langner1, P D Hasselback, G C Dunkley, S J Corber.   

Abstract

We conducted a telephone survey of 102 randomly selected Ottawa family physicians to determine their attitudes and practices regarding the treatment of hypercholesterolemia. Of the 102, 56% routinely measured serum cholesterol levels in all their patients over the age of 30 years, and 24% did so for patients in more restricted age ranges. The level at which they started dietary therapy averaged 6.95 mmol/L (270 mg/dl); for 25% it was less than 6.22 mmol/L (240 mg/dl). The level at which they started drug therapy averaged 8.9 mmol/L (345 mg/dl); for only 15% was it 7.23 mmol/L (280 mg/dl) or less. Two-thirds were unable to give numerical values to the serum cholesterol levels at which they started diet therapy, and 38% used the upper limits of laboratory normal values as an indication to start therapy. Our findings contrast markedly with results reported for US family physicians, who treat hypercholesterolemia much more aggressively. The variability in practices must be addressed if public campaigns to lower serum cholesterol levels are to be undertaken.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731100      PMCID: PMC1269270     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Feasibility of large-scale cholesterol screening: experience with a portable capillary-blood testing device.

Authors:  P Greenland; J C Levenkron; M G Radley; J G Baggs; R A Manchester; N L Bowley
Journal:  Am J Public Health       Date:  1987-01       Impact factor: 9.308

Review 2.  Cholesterol and coronary heart disease. A new era.

Authors:  S M Grundy
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

3.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

4.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

5.  Change in physician perspective on cholesterol and heart disease. Results from two national surveys.

Authors:  B Schucker; J T Wittes; J A Cutler; K Bailey; D R Mackintosh; D J Gordon; C M Haines; M E Mattson; R S Goor; B M Rifkind
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272

6.  Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

Authors:  G Oster; A M Epstein
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

7.  Population screening for cholesterol determination. A pilot study.

Authors:  E L Wynder; F Field; N J Haley
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

8.  Cholesterol reduction and life expectancy. A model incorporating multiple risk factors.

Authors:  W C Taylor; T M Pass; D S Shepard; A L Komaroff
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

  8 in total
  7 in total

1.  Cardiovascular disease. Physician attitudes toward prevention and treatment.

Authors:  A M Grant; T Niyonsenga; I Dion; E Delisle; M Xhignesse; R Bernier
Journal:  Can Fam Physician       Date:  1998-04       Impact factor: 3.275

2.  Cholesterol: controversy and confusion.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1990-04       Impact factor: 3.275

3.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

4.  Screening for hypercholesterolemia among Canadians: how much will it cost?

Authors:  S A Grover; L Coupal; R Fahkry; S Suissa
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

5.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.

Authors:  S A Grover; I Lowensteyn; K L Esrey; Y Steinert; L Joseph; M Abrahamowicz
Journal:  BMJ       Date:  1995-04-15

Review 6.  Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.

Authors:  Mohamed Hassan Elnaem; Mohamad Haniki Nik Mohamed; Hasniza Zaman Huri; Shah M Azarisman; Ramadan Mohamed Elkalmi
Journal:  J Pharm Bioallied Sci       Date:  2017 Apr-Jun

7.  General Practitioners involvement in enteral tube feeding at home: a qualitative study.

Authors:  Sharon M Madigan; Paul Fleming; Siobhan McCann; Marion E Wright; Domhnall MacAuley
Journal:  BMC Fam Pract       Date:  2007-05-15       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.